OBIO

Orchestra BioMed Holdings, Inc.

7.95 USD

Last updated Dec 9, 17:19 UTC

Yesterday HIGH

$7.99

Yesterday LOW

$7.3

52w HIGH

$23.39

52w LOW

$4.26

EPS

-0.38

PE

-20.92

Next Earnings

Jan 24, 2024

Overview News Government Trades

Orchestra BioMed Holdings, Inc. stock is up 52.88% since 30 days ago. The next earnings date is Jan 24, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 3 December’s closed higher than November.

Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Medical Equipment

Headquarters

-

Lisa Levin

Thu Jun 22, 2023

Steelcase, Commercial Metals And Other Big Stocks Moving Higher On Thursday

U.S. stocks traded mixed, with the Dow Jones dropping around 50 points on Thursday. Here are some big stocks recording gains in today’s session.
Benzinga Newsdesk

Wed Jun 7, 2023

Orchestra BioMed Appoints Andrew Taylor As Chief Financial Officer, Succeeding Michael Kaswan

Bill Little, previously Chief Operating Officer (COO) of Neovasc, Inc. through its acquisition by Shockwave Medical in April 2023, will lead efforts to forge further strategic collaborations in newly created Executive
richadhand@benzinga.com

Mon May 15, 2023

Chardan Capital Reiterates Buy on Orchestra BioMed Hldgs, Maintains $20 Price Target

Chardan Capital analyst Keay Nakae reiterates Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy and maintains $20 price target.
Benzinga Newsdesk

Fri May 12, 2023

Orchestra BioMed Hldgs Q1 EPS $(0.40) Misses $(0.28) Estimate, Sales $1.16M Beat $680.00K Estimate

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.28) by 42.86 percent. The company reported quarterly sales of $1.16 million which
Lisa Levin

Mon Apr 10, 2023

Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday.
Lisa Levin

Fri Mar 17, 2023

Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp.
Benzinga Insights

Tue Mar 7, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights

Mon Mar 6, 2023

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights

Fri Feb 24, 2023

Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
vishwanath@benzinga.com

Fri Feb 24, 2023

Piper Sandler Initiates Coverage On Orchestra BioMed Hldgs with Overweight Rating, Announces Price Target of $15

Piper Sandler analyst Matt O'Brien initiates coverage on Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Overweight rating and announces Price Target of $15.